ZHANG LEI,ROGERS BRUCE NELSON,O'NEIL STEVEN VICTOR
申请号：
AP2015008844
公开号：
AP2015008844A0
申请日:
2014.06.13
申请国别(地区):
AP
年份:
2015
代理人:
摘要：
The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof； processes for the preparation of； intermediates used in the preparation of； and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), age-related cognitive decline, dementia, and Parkinson's disease.
